The Medical Advisor

The European Medicines Agency (EMA) has issued a drug safety signal ( pdf ) regarding the potential risk of thyroid cancer associated with certain classes of medications that include semaglutide , the active ingredient in the widely used drugs Ozempic, approved for Type 2 diabetes, and Wegovy, approved for obesity. The medications in question are glucagon-like peptide-1 (GLP-1) receptor agonists. Their manufacturers, including Novo Nordisk, AstraZeneca, Eli Lilly, and Sanofi Winthrop, must submit supplementary information by July 26, 2023. A safety signal does not necessarily imply a direct causal relationship between a medicine and the reported adverse event. The purpose of assessing safety signals is to determine whether such a causal link exists between the medication and the reported adverse event. “Novo Nordisk is aware of the signal and the request by EMA and will deliver a thorough assessment of all relevant data to elucidate this topic,” Lars Otto Andersen-Lange, media relation

Research shows your body’s microbiome has nearly 39 trillion bacteria.[[1] During early years, your family, dietary intake and environmental exposure contribute to the variety in your microbiome, influencing your lifelong health. Everyday activities such as brushing your teeth, eating, kissing someone or handling a family pet also affect your microbiome. Buy on Amazon This composition may be as distinct to you as a fingerprint and plays an enormous role in disease prevention, and influences the function of your skin, lungs, breast and liver.[2] Harmful bacteria can trigger illness and disease, which is frequently treated with antibiotics. Of the 10 most commonly prescribed, two are from the antibiotic class of fluoroquinolones.[3] The Food and Drug Administration (FDA) first added a boxed warning to fluoroquinolones in 2008, due to the increased risk for tendinitis and tendon rupture.[4] Boxed warnings, also referred to as black box warnings, appear on prescription drug labels designed

The World Health Organization (WHO) has warned that cases of dengue fever could reach record highs this year. Dengue rates are rising globally, with reported cases since 2000 up eight-fold to 4.2 million in 2022, a WHO official  said on July 21 , 2023. In January 2023, the WHO claimed that dengue is the world’s fastest-spreading tropical disease and alleged it could be a “pandemic threat.” The disease was found in Sudan’s capital Khartoum for the first time on record, according to a health ministry report in March, while Europe has reported a surge in cases and Peru declared a state of emergency in most regions. About half of the world’s population is now at risk, Raman Velayudhan, a specialist at the WHO’s control of neglected tropical diseases department, told journalists in Geneva on Friday. Cases reported to the WHO hit an all-time high in 2019 with 5.2 million cases in 129 countries, said Mr. Velayudhan via video link. This year the world is on track for “4 million plus” cases, de